165 related articles for article (PubMed ID: 986203)
1. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
Uspenskiĭ AE; Korobov NV
Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
[TBL] [Abstract][Full Text] [Related]
2. The effect of disulfiram on the restoration of the response to tyramine by dopamine and alpha-methyl-dopa in the reserpine-treated cat.
Musacchio JM; Bhagat B; Jackson CJ; Kopin IJ
J Pharmacol Exp Ther; 1966 May; 152(2):293-7. PubMed ID: 5944371
[No Abstract] [Full Text] [Related]
3. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
Singh A; Naidu PS; Kulkarni SK
Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
[TBL] [Abstract][Full Text] [Related]
4. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
5. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
[TBL] [Abstract][Full Text] [Related]
6. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
[TBL] [Abstract][Full Text] [Related]
7. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
8. [Effect of catapresan, alpha-methyldopa and L-DOPA on segmental mechanisms of vasomotor regulation].
Zaĭtsev AA
Farmakol Toksikol; 1978; 41(6):690-3. PubMed ID: 720580
[No Abstract] [Full Text] [Related]
9. Effect of angiotensin on the central action of dopamine.
Braszko J; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
[TBL] [Abstract][Full Text] [Related]
10. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
[TBL] [Abstract][Full Text] [Related]
11. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
Uspenskiĭ AE; Dabagov NS; Skoldinov AP
Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
[TBL] [Abstract][Full Text] [Related]
13. [Role of the dopaminergic structures of the kidney in the renal effects of euphyllin].
Kantariia VA
Farmakol Toksikol; 1977; 40(3):331-3. PubMed ID: 902724
[TBL] [Abstract][Full Text] [Related]
14. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.
Alam M; Mayerhofer A; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):117-24. PubMed ID: 15084427
[TBL] [Abstract][Full Text] [Related]
15. [Modifications of vascular reactivity in the cat with reserpine, guanethidine and alpha-methyl-dopa].
Miele E
Arch Ital Sci Farmacol; 1965; 15(1):79-81. PubMed ID: 5871026
[No Abstract] [Full Text] [Related]
16. Studies on the pharmacology of alpha-methyl-3,4-dihydroxyphenylalanine (alpha-methyl-dopa) and alpha-methyl-norepinephrine. I.
Kadzielawa K
Int J Neuropharmacol; 1967 Nov; 6(6):435-52. PubMed ID: 4296969
[No Abstract] [Full Text] [Related]
17. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
Singh A; Naidu PS; Kulkarni SK
Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
[TBL] [Abstract][Full Text] [Related]
18. On the mechanism of L-dopa-induced postural hypotension in the cat.
Dhasmana KM; Spilker BA
Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
[TBL] [Abstract][Full Text] [Related]
19. Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.
Wick MM
Cancer Treat Rep; 1979 Jun; 63(6):991-7. PubMed ID: 466656
[TBL] [Abstract][Full Text] [Related]
20. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
Antonaccio MJ; Kerwin L
J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
